Lavipharm S.A. (ATH: LAVI)

Lavipharm Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 17, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	134	134	64	30	24	11
Market Cap Growth	39.60%	107.29%	117.58%	23.40%	113.64%	57.14%
Enterprise Value	156	161	98	66	62	50
Last Close Price	0.79	0.80	0.38	1.62	1.31	0.61
PE Ratio	18.74	71.42	77.29	17.20	11.47	2.11
PS Ratio	2.59	2.62	1.65	0.75	0.64	0.33
PB Ratio	2.60	3.12	1.60	-2.98	-2.06	-0.78
P/TBV Ratio	20.29	78.88	-	-	-	-
P/FCF Ratio	-	-	-	13.52	17.47	23.56
P/OCF Ratio	60.54	470.50	19.27	7.21	8.42	3.88
EV/Sales Ratio	3.05	3.16	2.50	1.66	1.64	1.50
EV/EBITDA Ratio	20.01	20.05	19.70	12.35	9.88	10.46
EV/EBIT Ratio	43.74	36.66	24.01	14.66	11.97	13.14
EV/FCF Ratio	-39.55	-	-	30.16	44.99	105.58
Debt / Equity Ratio	0.61	0.76	0.92	-3.76	-3.39	-2.83
Debt / EBITDA Ratio	4.01	3.74	6.68	6.28	6.03	8.06
Debt / FCF Ratio	-	-	-	17.03	28.69	85.35
Asset Turnover	0.43	0.44	0.47	0.77	0.75	0.74
Inventory Turnover	1.60	2.08	2.18	2.70	2.96	3.24
Quick Ratio	0.62	0.66	0.70	0.35	0.67	0.72
Current Ratio	1.24	1.28	1.00	0.63	1.24	1.21
Return on Equity (ROE)	15.20%	4.80%	6.25%	-	-	-
Return on Assets (ROA)	1.85%	2.40%	3.04%	5.46%	6.46%	5.25%
Return on Capital (ROIC)	2.78%	3.59%	4.84%	10.22%	11.93%	10.11%
Earnings Yield	5.53%	1.40%	1.29%	5.82%	8.72%	47.40%
FCF Yield	-2.96%	-2.87%	-50.06%	7.40%	5.72%	4.24%
Buyback Yield / Dilution	-73.56%	-679.84%	-26.42%	-	-	-
Total Shareholder Return	-73.56%	-679.84%	-26.42%	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.